secwatch.observer — SEC 8-K summary
======================================

Issuer:     American Well Corp (AMWL)
CIK:        0001393584
Form:       8-K
Filed at:   2025-01-10T23:59:59+00:00
Accession:  0000950170-25-004254
Event type: m_and_a
Sentiment:  neutral
Materiality: 0.70
Item codes: 1.01, 2.01, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Amwell sells telepsychiatry business to Avel eCare for $21M cash plus earn-out
------------------------------------------------------------------------------

- Upfront cash $20.7M (1.1x trailing 12-month revenue) plus earn-out of 0.4x next 12-month revenues.
- Sale closed Jan 8; includes APC technology, personnel, Asana network. Reiterates FY2024 revenue guidance $247-252M.
- Reiterates positive cash flow goal in 2026. Pro forma shows ~$24M annual revenue removed and ~$10.4M estimated gain on sale.
- Pro forma for 9 months to Sep 30, 2024: net loss improved from $(165.5M) to $(164.0M), EPS from $(11.13) to $(11.03).

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1393584/000095017025004254/0000950170-25-004254-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1393584/000095017025004254/amwl-20250108.htm
  HTML page:      https://secwatch.observer/filing/0000950170-25-004254

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer